MOREPEN LABORATORIES
Quarterly Results Analysis [Mar2025]
MOREPEN LABORATORIES Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹466 Cr | ₹453 Cr | ₹438 Cr | ₹455 Cr | ₹423 Cr | ₹445 Cr | ₹422 Cr | ₹401 Cr |
Expenses | ₹424 Cr | ₹417 Cr | ₹394 Cr | ₹404 Cr | ₹375 Cr | ₹394 Cr | ₹388 Cr | ₹375 Cr |
Operating Income | ₹42 Cr | ₹36 Cr | ₹44 Cr | ₹52 Cr | ₹48 Cr | ₹51 Cr | ₹34 Cr | ₹26 Cr |
Other Income | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr |
Interest | ₹5 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹16 Cr | ₹5 Cr | ₹2 Cr | ₹6 Cr | ₹10 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
Profit Before Tax | ₹26 Cr | ₹35 Cr | ₹46 Cr | ₹48 Cr | ₹42 Cr | ₹44 Cr | ₹29 Cr | ₹21 Cr |
Profit After Tax | ₹20 Cr | ₹27 Cr | ₹35 Cr | ₹36 Cr | ₹29 Cr | ₹32 Cr | ₹21 Cr | ₹15 Cr |
EPS | ₹0.37 | ₹0.49 | ₹0.64 | ₹0.71 | ₹0.55 | ₹0.63 | ₹0.42 | ₹0.29 |
Industry Peers & Returns | 1W | 1M | 1Y |
MOREPEN LABORATORIES | -0.2% | -4.7% | 13.1% |
SUN PHARMACEUTICAL INDUSTRIES | 0.9% | -0.1% | 10.9% |
DIVIS LABORATORIES | 3.7% | 3% | 46.5% |
CIPLA | 0.2% | 2.8% | 1.6% |
TORRENT PHARMACEUTICALS | 7.3% | 7.4% | 19.8% |
DR REDDYS LABORATORIES | -4% | 2.6% | 7.2% |
MANKIND PHARMA | 0.6% | -6.1% | 9.3% |
ZYDUS LIFESCIENCES | 2.6% | 6.4% | -8% |
LUPIN | 0.4% | -1.1% | 22.2% |
MOREPEN LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 2.89 % |
Y-o-Y | 10.11 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹466 Cr | 2.89 | |
Dec2024 | ₹453 Cr | 3.44 | |
Sep2024 | ₹438 Cr | -3.84 | |
Jun2024 | ₹455 Cr | 7.60 | |
Mar2024 | ₹423 Cr | -4.83 | |
Dec2023 | ₹445 Cr | 5.40 | |
Sep2023 | ₹422 Cr | 5.17 | |
Jun2023 | ₹401 Cr | - |
MOREPEN LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 16.89 % |
Y-o-Y | -12.68 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹42 Cr | 16.89 | |
Dec2024 | ₹36 Cr | -17.99 | |
Sep2024 | ₹44 Cr | -14.63 | |
Jun2024 | ₹52 Cr | 6.70 | |
Mar2024 | ₹48 Cr | -4.33 | |
Dec2023 | ₹51 Cr | 50.54 | |
Sep2023 | ₹34 Cr | 28.76 | |
Jun2023 | ₹26 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 13.66 % |
Y-o-Y | -20.72 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 9.07% | 13.66 | |
Dec2024 | 7.98% | -20.75 | |
Sep2024 | 10.07% | -11.20 | |
Jun2024 | 11.34% | -0.87 | |
Mar2024 | 11.44% | 0.62 | |
Dec2023 | 11.37% | 42.84 | |
Sep2023 | 7.96% | 22.27 | |
Jun2023 | 6.51% | - |
MOREPEN LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -23.89 % |
Y-o-Y | -29.33 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹20 Cr | -23.89 | |
Dec2024 | ₹27 Cr | -23.42 | |
Sep2024 | ₹35 Cr | -3.65 | |
Jun2024 | ₹36 Cr | 25.85 | |
Mar2024 | ₹29 Cr | -10.17 | |
Dec2023 | ₹32 Cr | 50.50 | |
Sep2023 | ₹21 Cr | 45.27 | |
Jun2023 | ₹15 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -25.98 % |
Y-o-Y | -35.79 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 4.36 % | -25.98 | |
Dec2024 | 5.89 % | -26.01 | |
Sep2024 | 7.96 % | 0.13 | |
Jun2024 | 7.95 % | 17.08 | |
Mar2024 | 6.79 % | -5.69 | |
Dec2023 | 7.2 % | 42.86 | |
Sep2023 | 5.04 % | 38.08 | |
Jun2023 | 3.65 % | - |
MOREPEN LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -24.49 % |
Y-o-Y | -32.73 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹0.37 | -24.49 | |
Dec2024 | ₹0.49 | -23.44 | |
Sep2024 | ₹0.64 | -9.86 | |
Jun2024 | ₹0.71 | 29.09 | |
Mar2024 | ₹0.55 | -12.70 | |
Dec2023 | ₹0.63 | 50.00 | |
Sep2023 | ₹0.42 | 44.83 | |
Jun2023 | ₹0.29 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD